These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5311472)

  • 41. [Water-sodium depletion and clonidine in severe arterial hypertension].
    Sobel A; Safar M; Milliez P
    Maroc Med; 1972 Apr; 52(556):187-92. PubMed ID: 5042074
    [No Abstract]   [Full Text] [Related]  

  • 42. Use of moxonidine in elderly patients with resistant hypertension.
    Martin U; Hill C; O' Mahony D
    J Clin Pharm Ther; 2005 Oct; 30(5):433-7. PubMed ID: 16164488
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Long-term testing of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride with special reference to the effect on blood pressure and carbohydrate metabolism].
    Krämer D; Krause W; Renner H
    Arzneimittelforschung; 1970 Apr; 20(4):519-21. PubMed ID: 5467817
    [No Abstract]   [Full Text] [Related]  

  • 44. [Use of imidazoline derivatives in patients with arterial hypertension].
    Ol'binskaia LI; Enikeeva NB; Sinopal'nikov AI
    Klin Med (Mosk); 1980 Jul; 58(7):28-33. PubMed ID: 7289460
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effect of moxonidine monotherapy and in combination with melatonin on hemodynamic parameters in patients with arterial hypertension].
    Zaslavskaia RM; Komarov FI; Shakirova AN; Teĭblium MM; Akhmetov KZh
    Klin Med (Mosk); 2000; 78(4):41-4. PubMed ID: 10833890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of arterial hypertension: clinical observations on a new pharmacologic association].
    Migheli B; Campus S; Accatino G; Dessy P; Anselmino A
    Minerva Med; 1965 Sep; 56(75):3211-3. PubMed ID: 5319789
    [No Abstract]   [Full Text] [Related]  

  • 47. Selective imidazoline agonist moxonidine in obese hypertensive patients.
    Sanjuliani AF; de Abreu VG; Francischetti EA
    Int J Clin Pract; 2006 May; 60(5):621-9. PubMed ID: 16700870
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical assessment of prolonged therapy of patients with hypertension and diabetes with imidazoline receptor agonist moxonidine].
    Trusov VV; Aksenov KV; Filimonov MA
    Kardiologiia; 2002; 42(2):50-3. PubMed ID: 12494208
    [No Abstract]   [Full Text] [Related]  

  • 49. [A new substance with antihypertensive effect: clonidine].
    Orlandi S
    Clin Ter; 1970 May; 53(4):357-61. PubMed ID: 5506642
    [No Abstract]   [Full Text] [Related]  

  • 50. [New chemotherapy in arterial hypertension].
    Chiti E
    Minerva Med; 1971 Nov; 62(84):4143-8. PubMed ID: 5136617
    [No Abstract]   [Full Text] [Related]  

  • 51. [Moxonidine. A new antihypertensive agent of central action].
    Leães CG; Rosito GA
    Arq Bras Cardiol; 1998 Jun; 70(6):443-8. PubMed ID: 9713089
    [No Abstract]   [Full Text] [Related]  

  • 52. Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study.
    Sharma AM; Wagner T; Marsalek P
    J Hum Hypertens; 2004 Sep; 18(9):669-75. PubMed ID: 15269705
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of hypertension with clonidine].
    Siitonen L; Koskinen P; Vuorio S; Bäckman H
    Duodecim; 1970; 86(14):818-25. PubMed ID: 5447795
    [No Abstract]   [Full Text] [Related]  

  • 54. A comparative trial of timolol and flutonidin as antihypertensive agents.
    Salvadeo A; Segagni S; Villa G; Galli F; Piazza W; Bovio G
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):78-84. PubMed ID: 7037661
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical observations on the treatment of arterial hypertension with a new drug of a guanidine type: cyclazenine].
    Montagnani M; Bayelli PF; Antonelli A; Barducci O
    Clin Ter; 1968 Sep; 46(5):419-38. PubMed ID: 5747193
    [No Abstract]   [Full Text] [Related]  

  • 56. [Hemodynamic changes following adminstration of dichlorophenylamino-imidazoline hydrochloride in acute and chronic experiments].
    Schneider KW; Gattenlöhner W; Müller W
    Verh Dtsch Ges Inn Med; 1967; 73():611-6. PubMed ID: 4873599
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical experience with Catapresan].
    Laux L; Angelmann W
    Med Monatsschr; 1967 Apr; 21(4):186-7. PubMed ID: 5584446
    [No Abstract]   [Full Text] [Related]  

  • 58. [Therapy of elemental arterial hypertension by a new imidazole derivative].
    Valdés EF; Mendoza R; Gonçalves N
    Prensa Med Argent; 1967 Nov; 54(37):2068-71. PubMed ID: 5613692
    [No Abstract]   [Full Text] [Related]  

  • 59. [Policy of antihypertensive therapy in arterial hypertension in the elderly. II].
    Gurevich MA
    Klin Med (Mosk); 2002; 80(9):9-13. PubMed ID: 12416217
    [No Abstract]   [Full Text] [Related]  

  • 60. Moxonidine: a new antiadrenergic antihypertensive agent.
    Prichard BN; Graham BR; Owens CW
    J Hypertens Suppl; 1999 Aug; 17(3):S41-54. PubMed ID: 10489098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.